Combined effects of olaparib and cytotoxic agents to triple negative breast cancer cells

被引：1
|
作者：
Takashima, Yuki [1 ]
Hashimoto, Jun [2 ]
Kitamura, Yuka [3 ]
Shimma, Shuichi [1 ]
Fujiwara, Yasuhiro [2 ]
Koizumi, Fumiaki [3 ]
Tamura, Kenji [2 ]
Hamada, Akinobu [1 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
[2] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo, Japan
[3] Natl Canc Ctr, Shien Lab, Tokyo, Japan
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-1678
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1678
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Analysis of Adaptive Olaparib Resistance Effects on Cisplatin Sensitivity in Triple Negative Breast Cancer Cells
    Gajan, Ambikai
    Sarma, Ashapurna
    Kim, Seongho
    Gurdziel, Katherine
    Wu, Gen Sheng
    Shekhar, Malathy P.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [2] SYNERGISTIC INTERACTION BETWEEM OLAPARIB, A PARP INHIBITOR, AND CYTOTOXIC AGENT IN TRIPLE NEGATIVE BREAST CANCER
    Hashimoto, J.
    Kitamura, Y.
    Takashima, Y.
    Kodera, Y.
    Shimma, S.
    Hamada, A.
    Fujiwara, Y.
    Koizumi, F.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2013, 24
  • [3] Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
    Swanner, Jessica
    Mims, Jade
    Carroll, David L.
    Akman, Steven A.
    Furdui, Cristina M.
    Torti, Suzy V.
    Singh, Ravi N.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 : 3937 - 3953
  • [4] Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer
    Jang, Na Young
    Kim, Dan Hyo
    Cho, Bong Jun
    Choi, Eun Jung
    Lee, Jong-Soo
    Wu, Hong-Gyun
    Chie, Eui Kyu
    Kim, In Ah
    BMC CANCER, 2015, 15
  • [5] Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer
    Na Young Jang
    Dan Hyo Kim
    Bong Jun Cho
    Eun Jung Choi
    Jong-Soo Lee
    Hong-Gyun Wu
    Eui Kyu Chie
    In Ah Kim
    BMC Cancer, 15
  • [6] Neoadjuvant olaparib monotherapy in primary triple negative breast cancer
    Eikesdal, H. P.
    Yndestad, S.
    Blix, E. S.
    Lundgren, S.
    Vagstad, G.
    Espelid, H.
    Gilje, B.
    Janssen, E. A.
    Geisler, J.
    Aas, T.
    Aase, H.
    Knappskog, S.
    Lonning, P. E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [7] Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer Trial
    Loap, Pierre
    Loirat, Delphine
    Berger, Frederique
    Rodrigues, Manuel
    Bazire, Louis
    Pierga, Jean-Yves
    Vincent-Salomon, Anne
    Laki, Fatima
    Boudali, Latifa
    Raizonville, Laurence
    Mosseri, Veronique
    Jochem, Anne
    Eeckhoutte, Alexandre
    Diallo, Mamadou
    Stern, Marc-Henri
    Fourquet, Alain
    Kirova, Youlia
    JAMA ONCOLOGY, 2022, 8 (12) : 1802 - 1808
  • [8] PARTNER Trial: Neoadjuvant olaparib in triple negative breast cancer (TNBC)
    Abraham, Jean E.
    Pinilla, Karen
    Grybowicz, Louise
    Dayimu, Alimu
    Demiris, Nikolaos
    Harvey, Caron
    Drewett, Lynsey M.
    Lucey, Rebecca
    Fulton, Alexander
    Roberts, Anne N.
    Worley, Joanna R.
    Chhabra, Anita
    Qian, Wendi
    Hardy, Richard M.
    Chan, Stephen
    Hickish, Tamas
    Tripathi, Devashish
    Venkitaraman, Ramachandran
    Persic, Mojca
    Aslam, Shahzeena
    Glassman, Daniel
    Raj, Sanjay
    Borley, Annabel
    Braybrooke, Jeremy P.
    Sutherland, Stephanie
    Staples, Emma
    Scott, Lucy C.
    Davies, Mark
    Palmer, Cheryl A.
    Moody, Margaret
    Churn, Mark J.
    Newby, Jacqueline C.
    Mukesh, B. Mukesh
    Chakrabarti, Amitabha
    Roylance, Rebecca R.
    Schouten, Philip C.
    Levitt, Nicola
    McAdam, Karen
    Armstrong, Anne C.
    Copson, Ellen R.
    McMurtry, Emma
    Tischkowitz, Marc
    Provenzano, Elena
    Earl, Helena
    CANCER RESEARCH, 2024, 84 (07)
  • [9] Olaparib monotherapy as primary treatment in unselected triple negative breast cancer
    Eikesdal, H. P.
    Yndestad, S.
    Elzawahry, A.
    Llop-Guevara, A.
    Gilje, B.
    Blix, E. S.
    Espelid, H.
    Lundgren, S.
    Geisler, J.
    Vagstad, G.
    Venizelos, A.
    Minsaas, L.
    Leirvaag, B.
    Gudlaugsson, E. G.
    Vintermyr, O. K.
    Aase, H. S.
    Aas, T.
    Balmana, J.
    Serra, V
    Janssen, E. A. M.
    Knappskog, S.
    Lonning, P. E.
    ANNALS OF ONCOLOGY, 2021, 32 (02) : 240 - 249
  • [10] Triple negative breast cancer: agents and strategies
    Cottu, P. -H.
    ONCOLOGIE, 2007, 9 : S162 - S164
12345